Len Teti Authors Blog Post for European Tax Blog
February 14, 2020
Cravath partner J. Leonard Teti II authored a blog post entitled “US Government Finalizes Rules on Transfers to Partnerships with Related Foreign Partners,” which was published by European Tax Blog on February 10, 2020. The post discusses recently finalized regulations aimed at preventing U.S. taxpayers from achieving tax‑free transfers of appreciated property to a partnership with related foreign partners.
Related Practices & Industries
Authors
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
February 03, 2020
RELX’s Acquisition of Emailage
On February 3, 2020, LexisNexis® Risk Solutions, part of RELX, a global provider of information‑based analytics and decision tools for professional and business customers, announced that it has entered into an agreement to acquire Emailage®, a global leader in fraud prevention and risk management through email intelligence‑based fraud risk scoring solutions. Cravath is representing RELX in connection with the transaction.
Deals & Cases
January 13, 2020
RELX’s Acquisition of ID Analytics
On January 13, 2020, LexisNexis® Risk Solutions, part of RELX, a global provider of information‑based analytics and decision tools for professional and business customers, announced that it has entered into an agreement to acquire ID Analytics, a provider of credit and fraud risk solutions for enterprises. ID Analytics will become part of the LexisNexis Risk Solutions Business Services group, which uses data resources, technology, linking and analytics to deliver actionable insights that enable businesses to better analyze and assess risk. Cravath is representing RELX in connection with the transaction.
Deals & Cases
December 09, 2019
Janssen Biotech, Inc.’s Acquisition of Bermekimab from XBiotech Inc.
On December 7, 2019, Janssen Biotech, Inc. (“Janssen Biotech”), a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody in Phase 2 development for the treatment of atopic dermatitis and hidradenitis suppurativa, which are chronic, immune-mediated skin diseases. Cravath is representing Janssen Biotech in connection with the transaction.
Deals & Cases
November 24, 2019
AP WIP Investments Holdings, LP’s Acquisition by Landscape Acquisition Holdings Limited
On November 19, 2019, Landscape Acquisitions Holdings Limited (“Landscape”) announced that it has entered into a definitive agreement to acquire AP WIP Investments Holdings, LP, one of the largest global aggregators of real property interests underlying wireless telecommunications cell sites, for consideration of approximately $860 million consisting of cash, shares and assumption of debt. Cravath is representing AP WIP Investments Holdings, LP in connection with the transaction.
